The diagnostics advisory committee considered evidence on MRI-based technologies for assessing non-alcoholic fatty liver disease (NAFLD) from several sources, including a diagnostics assessment report ...

Researchers from France have shown that hepatobiliary MR contrast agent uptake can predict survival in patients with resectable hepatocellular carcinoma (HCC) as well as 18 F-FDG PET/CT can. They ...

Calvin Sun was a healthy 37-year-old when a full-body MRI scan showed a cyst in his kidney. Sun saw a urologist who was cautiously optimistic that it wasn’t cancerous and offered him a surgery ...

Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ANN ARBOR, Mich., ...

Non-alcoholic fatty liver disease (NAFLD) is the term for a range of conditions caused by a build‑up of fat in the liver. NAFLD develops in 4 stages: simple fatty liver (steatosis): a largely harmless ...